Utipro® Plus AF available for launch
We are pleased to announce the availability for launch of a new formulation of UTIPRO® PLUS, our product for uncomplicated UTIs.
We are pleased to announce the launch of UTIPRO® PLUS, our product for uncomplicated UTIs, in Finland.
The product is commercialized over the Finnish territory under the umbrella brand UrinCUR / Utipro plus and it is distributed by RFSU, our partner for the product on the Swedish and Norwegian territory as well.
We are glad inform you about a recent publication to further support the usefulness of mucoprotection in the relief of symptoms and in the prevention of recurrences in uncomplicated UTIs
The trial "Xyloglucan + Gelose Combination versus Placebo as Adjuvant Therapy to First-Line Antimicrobials for Uncomplicated Urinary Tract Infection in Adults" has been published on Urologia Internationalis.
https://www.ncbi.nlm.nih.gov/pubmed/30889607
In the study, safety and efficacy of a Xyloglucan based medical device were investigated as adjuvant therapy to first-line antimicrobials for treatment of uncomplicated UTIs in adults.